top of page
We are creating the future of vaccinations and drug delivery through painless, dissolving microneedle patches.
DendriBio is in pre-clinical development of stable, painless and simple vaccine and drug delivery via novel, dissolving microneedle arrays.
Microneedle arrays use our skin's own highly evolved and efficient immune response, making transdermal delivery as good or better than intramuscular injection.
10-15 minute painless dissolve time
Dose sparing opportunity with highly customizable arrays and loading
Novel and scalable
NO SHARPS DISPOSAL
RECONSTITUTION NOT REQUIRED
ELIMINATE COLD CHAIN
pandemic reach and readiness
Faster pandemic response with increased vaccination coverage into developing countries.
UC Irvine Institute for Immunology
UNCW Dept. of Chemistry and Biochemistry
Queens University Belfast
SRI International Biosciences Division
PROOF OF CONCEPT
We have completed proof-of-concept validation in a collaborative university study, and are currently conducting immunogenicity studies with our Dissolving Microneedle Array Technology (DMAT).
bottom of page